TrialThe Lancet. Neurology2013

High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial.

Myron D Ginsberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.